Medtronic (FRA:2M6) FFO


FRA:2M6 Medtronic PLC FRA:2M6
78 GF Score
Price €71.04
GF Value €87.17
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic FFO?

FFO (Funds from operations) only applies to REITs.

FRA:2M6
78GF Score
Medtronic PLC FRA:2M6
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medtronic (FRA:2M6) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of €71.04 is trading 18.5% below its estimated GF Value™ of €87.17. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for FRA:2M6:

  • FFO:
  • GF Value™: €87.17 vs. price of €71.04 (18.5% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:2M6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
78GF Score

Get the complete analysis for FRA:2M6

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.04
Price
€87.17
GF Value